| Literature DB >> 26645639 |
Gemma Hunting1, Nida Shahid2, Yeva Sahakyan3, Iris Fan4, Crystal R Moneypenny5, Aleksandra Stanimirovic6, Taylor North7, Yelena Petrosyan8, Murray D Krahn9, Valeria E Rac10.
Abstract
BACKGROUND: Despite research demonstrating the potential effectiveness of Telehomecare for people with Chronic Obstructive Pulmonary Disease and Heart Failure, broad-scale comprehensive evaluations are lacking. This article discusses the qualitative component of a mixed-method program evaluation of Telehomecare in Ontario, Canada. The objective of the qualitative component was to explore the multi-level factors and processes which facilitate or impede the implementation and adoption of the program across three regions where it was first implemented.Entities:
Mesh:
Year: 2015 PMID: 26645639 PMCID: PMC4673764 DOI: 10.1186/s12913-015-1196-2
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Figure 1A multi-level framework predicting implementation outcomes. Modified from Chaudoir et al. Implementation Science 2013, 8:22
Study participant inclusion criteria
| Stakeholder group | Inclusion criteria |
|---|---|
| Patients | • Consented to: a) participate in the program; and b) be contacted by the study team for evaluation purposes |
| Telehomecare program patient eligibility criteria: | |
| • Diagnosed with HF or COPD (with or without co-morbid conditions) | |
| Health Care Providers | • Referred a patient to the Telehomecare program (any health care provider) |
| Technicians | • Involved in the set-up of Telehomecare equipment at patients’ homes |
| Administrators | • Administrators of the Telehomecare program as a larger network of care such as clinical service managers, program coordinators, etc. |
| Decision Makers | • Decision Makers involved in the Telehomecare program as a larger network of care such as regional program managers, key members of the LHIN, OTN etc. |
Patient participant information
| PT ID | Gender | Age | Diagnosis | LHIN | PT ID | Gender | Age | Diagnosis | LHIN |
|---|---|---|---|---|---|---|---|---|---|
| PT 018 | Female | 61 | COPD | CW | PT 110+ | Male | 92 | HF | TC |
| PT 030 | Male | 83 | COPD | CW | PT 125 | Male | 75 | NA | NE |
| PT 031 | Male | 80 | HF | CW | PT 128 | Female | 65 | COPD | CW |
| PT 032 | Male | 71 | HF | CW | PT 133 | Male | 79 | HF | NE |
| PT 039+ | Female | 77 | COPD | TC | PT 134 | Male | 65 | NA | NE |
| PT 044 | Female | 76 | COPD | NE | PT 135+ | Female | 79 | HF | NE |
| PT 052 | Female | 84 | COPD | TC | PT 136+ | Female | 67 | COPD | NE |
| PT 053 | Male | 78 | COPD | TC | PT 137+ | Male | 75 | COPD | NE |
| PT 055 | Female | 50 | COPD | TC | PT 138+ | Female | 80 | COPD | NE |
| PT 073 | Male | 61 | NA | NE | PT 139+ | Female | 78 | HF | NE |
| PT 094+ | Female | 87 | HF | CW | PT 140 | Female | 70 | COPD | NE |
| PT 095+ | Male | 83 | HF | CW | PT 141+ | Male | 51 | HF | TC |
| PT 097+ | Male | 67 | COPD | TC | PT 142+ | Female | 56 | HF | TC |
| PT 098+ | Female | 37 | HF | CW | PT 143+ | Female | 86 | HF | TC |
| PT 099 | Male | 56 | COPD | TC | PT 144+ | Female | 84 | HF | TC |
| PT 102+ | Male | 69 | COPD | TC | PT 148a | Male | 76 | COPD | CW |
| PT 103 | Male | 62 | COPD | NE | PT 149 | Male | 75 | COPD | TC |
| PT 106+ | Female | 71 | HF | NE | PT 150a | Female | 77 | HF | NE |
| PT 107+ | Male | 73 | COPD | CW | PT 152+ | Male | 94 | HF | TC |
| PT 109+ | Female | 82 | HF | NE |
adropped out of program
+completed program
NA information not available
Conducted observations & interviews
| Method/ Stakeholder | Central West | Toronto Central | North East |
|---|---|---|---|
| Observations (total) | ~10 h | ~15 h | ~8 h |
| Interviews (total) | 25 | 26 | 34 |
| HCPs (total) | 7 | 8 | 8 |
| Physicians | 2 | 3 | 2 |
| Nurses | 5 | 5 | 6 |
| Administrators | 5 | 2 | 5 |
| Decision Makers | 3 | 2 | 6 |
| Patients | 10 | 14 | 15 |
| Technicians | 2 (non-specific LHIN) | ||
| Decision Makers | 2 (non-specific LHIN) | ||